Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Immuron Limited ( (AU:IMC) ).
Immuron Limited has announced a proposed issue of 2,579,760 ordinary fully paid securities, with a proposed issue date of August 1, 2025. This strategic move aims to bolster the company’s financial position, potentially enhancing its market presence and offering new investment opportunities for stakeholders.
More about Immuron Limited
Immuron Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of oral immunotherapy products for the treatment of immune-mediated diseases.
YTD Price Performance: -2.50%
Average Trading Volume: 1,000
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €11.04M
See more insights into IMC stock on TipRanks’ Stock Analysis page.